Jeffrey Hung
Stock Analyst at Morgan Stanley
(0)
# 4735
Out of 5,337 analysts
257
Total ratings
31.19%
Success rate
-20.69%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RARE Ultragenyx Pharmaceu... | Maintains: Overweight | 64 65 | 34.65 | 87.59% | 8 | May 9, 2025 | |
JAZZ Jazz Pharmaceuticals | Maintains: Overweight | 183 166 | 106.74 | 55.52% | 6 | May 7, 2025 | |
BCYC Bicycle Therapeutics | Maintains: Equal-Weight | 15 17 | 8.04 | 111.44% | 5 | May 6, 2025 | |
ENGN enGene Holdings | Maintains: Overweight | 37 34 | 3.02 | 1025.83% | 3 | Mar 11, 2025 | |
RYTM Rhythm Pharmaceutica... | Assumes: Overweight | 72 72 | 57.3 | 25.65% | 11 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 67 70 | 46.77 | 49.67% | 11 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 185 150 | 118.83 | 26.23% | 24 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 4 4 | 1.27 | 214.96% | 3 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 85 | 45.74 | 85.83% | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 38 35 | 7.2 | 386.11% | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 25 25 | 3.82 | 554.45% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 55 55 | 24.2 | 127.27% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 27 | 12.31 | 119.33% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Underweight | 5 | 3.79 | 31.93% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 20 20 | 17.17 | 16.48% | 24 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 70 67 | 29.99 | 123.41% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 17 12 | 5.88 | 104.08% | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 92 95 | n/a | n/a | 5 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 8.37 | 318.16% | 1 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 70 | 31.32 | 123.5% | 2 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 295 330 | n/a | n/a | 3 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 4 | 0.92 | 334.78% | 10 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 13 4 | 2.38 | 68.07% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 4 | 0.84 | 376.19% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 60 140 | 4.97 | 2716.9% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 14 | 1.27 | 1002.36% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 5 5 | 1.8 | 177.78% | 1 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 3 | 0.73 | 310.96% | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 14 | 1.3 | 976.92% | 7 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 21 | n/a | n/a | 4 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 4 2 | n/a | n/a | 3 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 50 10 | 2.04 | 390.2% | 3 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 30 | n/a | n/a | 6 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 22 | 44.5 | -50.56% | 10 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | n/a | n/a | 5 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 250 94 | n/a | n/a | 8 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 146 149 | 19.66 | 655.34% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 180 | n/a | n/a | 12 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 100 60 | 1.56 | 3746.15% | 5 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 3.19 | 88.09% | 9 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 121 225 | n/a | n/a | 9 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 54 | 0.44 | 12172.73% | 6 | May 8, 2020 |